Long-Term Durability of Transcatheter Aortic Valve Prostheses.

[1]  G. Lawrie,et al.  Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center , 2017, The Journal of thoracic and cardiovascular surgery.

[2]  B. Prendergast,et al.  Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ , 2017, European heart journal.

[3]  G. Tarantini,et al.  Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. , 2017, Annals of cardiothoracic surgery.

[4]  P. Pibarot,et al.  Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration. , 2017, Journal of the American College of Cardiology.

[5]  G. Guyatt,et al.  Structural valve deterioration after transcatheter aortic valve implantation , 2017, Heart.

[6]  P. Wenaweser,et al.  Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study , 2017, European heart journal.

[7]  V. Auffret,et al.  Bioprosthetic Valve Thrombosis. , 2017, Journal of the American College of Cardiology.

[8]  P. Serruys,et al.  Four-year experience with the CoreValve transcatheter heart valve. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  P. Serruys,et al.  Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  M. Mack,et al.  Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. , 2016, JACC. Cardiovascular imaging.

[11]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[12]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[13]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[14]  M. Carrier,et al.  Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. , 2013, The Annals of thoracic surgery.

[15]  R. Tominaga,et al.  A look at recent improvements in the durability of tissue valves , 2013, General Thoracic and Cardiovascular Surgery.

[16]  A. D. Cunningham,et al.  Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. , 2011, Journal of the American College of Cardiology.

[17]  M. Maganti,et al.  Aortic valve replacement with Hancock II bioprothesis with and without replacement of the ascending aorta. , 2011, The Annals of thoracic surgery.

[18]  P. Pibarot,et al.  Prosthetic Heart Valves Selection of the Optimal Prosthesis and Long-Term Management , 2009 .

[19]  Roland Hetzer,et al.  Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. , 2008, The Journal of thoracic and cardiovascular surgery.

[20]  K. Chartikavanij.  Aortic valve replacement. , 1969, Israel journal of medical sciences.